000 | 01849 a2200481 4500 | ||
---|---|---|---|
005 | 20250517161309.0 | ||
264 | 0 | _c20180413 | |
008 | 201804s 0 0 eng d | ||
022 | _a1742-2051 | ||
024 | 7 |
_a10.1039/c7mb00140a _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aZhao, Xiaoping | |
245 | 0 | 0 |
_aProteomic analysis reveals Xuesaitong injection attenuates myocardial ischemia/reperfusion injury by elevating pyruvate dehydrogenase-mediated aerobic metabolism. _h[electronic resource] |
260 |
_bMolecular bioSystems _cJul 2017 |
||
300 |
_a1504-1511 p. _bdigital |
||
500 | _aPublication Type: Journal Article | ||
650 | 0 | 4 |
_aAcetyl-CoA C-Acyltransferase _xgenetics |
650 | 0 | 4 | _aAnimals |
650 | 0 | 4 |
_aCardiovascular Agents _xpharmacology |
650 | 0 | 4 | _aCell Line |
650 | 0 | 4 |
_aDrugs, Chinese Herbal _xpharmacology |
650 | 0 | 4 |
_aEnergy Metabolism _xdrug effects |
650 | 0 | 4 | _aGene Expression Profiling |
650 | 0 | 4 | _aGene Expression Regulation |
650 | 0 | 4 |
_aHomeodomain Proteins _xgenetics |
650 | 0 | 4 | _aMale |
650 | 0 | 4 |
_aMitochondrial Trifunctional Protein, alpha Subunit _xgenetics |
650 | 0 | 4 |
_aMyocardial Reperfusion Injury _xdrug therapy |
650 | 0 | 4 |
_aMyocardium _xmetabolism |
650 | 0 | 4 |
_aMyocytes, Cardiac _xdrug effects |
650 | 0 | 4 |
_aNeuroprotective Agents _xpharmacology |
650 | 0 | 4 | _aOxidative Stress |
650 | 0 | 4 |
_aPhosphopyruvate Hydratase _xgenetics |
650 | 0 | 4 |
_aPyruvate Dehydrogenase (Lipoamide) _xgenetics |
650 | 0 | 4 | _aRats |
650 | 0 | 4 | _aRats, Sprague-Dawley |
650 | 0 | 4 |
_aSaponins _xpharmacology |
650 | 0 | 4 | _aSpectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization |
700 | 1 | _aZhang, Feng | |
700 | 1 | _aWang, Yi | |
773 | 0 |
_tMolecular bioSystems _gvol. 13 _gno. 8 _gp. 1504-1511 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1039/c7mb00140a _zAvailable from publisher's website |
999 |
_c27294727 _d27294727 |